Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells

Biochemical and Biophysical Research Communications

Volumn 243, Issue 3, 1998, Pages 816-820

  Huai Yun, Han ^a   Secrest, David T ^a   Mark, Karen S ^a   Carney, Debra ^a   Brandquist, Christine ^a   Elmquist, William F ^a   Miller, Donald W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID; CARRIER PROTEIN; FLUORESCEIN; GLUCURONIDE; GLUTATHIONE; GLYCOPROTEIN P; INDOMETACIN; MULTIDRUG RESISTANCE PROTEIN; PROBENECID;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CATTLE; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOBLOTTING; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0032562111     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.8132     Document Type: Article

References (24)

1. Audus K. L., Chikhale P. J., Miller D. W., Thompson S., Borchardt R. T. Adv. Drug Res. 23:1992;3-66.
2. Brightman M. W. Implications of the Blood-Brain Barrier and Its Manipulation. 1989;Plenum Publishing, New York. p. 53-84.
3. Schinkel A. H., Smit J. J. M., van Tellingem O., Beijnen J. H., Wagenaar E., van Deemter L., Mol C. A. A. M., van der Valk M. A., Robanu-Maandag E. C., Riele H. P. J., Berns A. J. M., Borst P. Cell. 77:1994;491-502.
4. Wang Q., Yang H., Miller D. W., Elmquist W. F. Biochem. Biophys. Res. Commun. 211:1995;719-726.
5. Barrand M. A., Bagrij T., Neo S. Y. Gen. Pharmacol. 28:1997;639-645.
6. Loe D. W., Deeley R. G., Cole S. P. C. Eur. J. Cancer. 32A:1996;945-957.
7. Hollo Z., Homolya L., Hegedus T., Sarkadi B. FEBS Lett. 383:1996;99-104.
8. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., Keppler D. Cancer Res. 56:1996;988-994.
9. Miller D. W., Audus K. L., Borchardt R. T. J. Tiss. Cult. Meth. 14:1992;217-224.
10. Miller D. W., Fontaine M., Kolar C., Lawson T. Cancer Lett. 107:1996;301-306.
11. Fontaine M., Elmquist W. F., Miller D. W. Life Sci. 59:1996;1521-1531.
12. Endo K., Maehara Y., Kusumoto T., Ichyoshi Y., Kuwano M., Sugimachi K. Int. J. Cancer. 68:1996;372-377.
13. Sarkadi B., Muller M., Hollo Z. Immunol. Lett. 54:1996;215-219.
14. Draper M. P., Martell R. L., Levy S. B. Br. J. Cancer. 75:1997;810-815.
15. Hegmann E. J., Bauer H. C., Kerbel R. S. Cancer Res. 52:1992;6969-6975.
16. Gervasoni J. E., Fields S. Z., Krishna S., Baker M. A., Rosado M., Thuraisamy K., Hindenburg A. A., Taub R. N. Cancer Res. 51:1991;4955-4963.
17. Flens M. J., Zaman G. J. R., van der Valk P., Izquierdo M. A., Schroeijers A. B., Scheffer G. L., van der Groep P., de Haas M., Meijer C. J. L. M., Scheper R. J. Am. J. Pathol. 148:1996;1237-1247.
18. Stride B. D., Valdimarsson G., Gerlach J. H., Wilson G. M., Cole S. P. C., Deeley R. G. Mol. Pharmacol. 49:1996;962-971.
19. Adkison K. D., Powers K. M., Artru A. A., Shen D. D. Epilepsy Res. 23:1996;95-104.
20. Deguchi Y., Inabe K., Tomiyasu K., Nozawa K., Yamada S., Kimura R. Pharm. Res. 12:1995;1838-1844.
21. Ackley D. C., Yokel R. A. Toxicology. 120:1997;89-97.
22. Riant P., Bree F., Urien S., Hamberger C., Albengres E., Tillement J. P. Fund. Clin. Pharmacol. 4:1990;105-114.
23. Deguchi Y., Nozawa K., Yamada S., Yokoyama Y., Kimura R. J. Pharmacol. Exp. Ther. 280:1997;551-560.
24. Wong S. L., Van Belle K., Sawchuk R. J. J. Pharmacol. Exp. Ther. 264:1993;899-909.